Hitachi Medical Systems Europe Holding AG
Stories about Heart arrhythmia
-
Language:
English
- Media:
- Period:
- Period:Total
- more
Carag First-ever Septal Occluder With Bioresorbable, Metal-free Framework Available to Patients Through New European Registry
moreTechnische Universität München
Gene scissors for Duchenne muscular dystrophy
moreApp-based ECG CardioSecur Now Available in South America
One documentmoreCardioSecur introduces 3D-ECG for virtual trials at Clinical Trials Europe
One documentmoreEuropean Results From Global ETNA-AF Registry Show Low Bleeding and Low Cardiovascular Event Rates in Elderly NVAF Patients on LIXIANA® (edoxaban)
moreDaiichi Sankyo Presents Positive Results of the ENTRUST-AF PCI Study of LIXIANA® (edoxaban) in Patients with Atrial Fibrillation
moreETNA-AF Registry Data Provide Real-world Evidence of the Efficacy and Safety Profile of LIXIANA® (edoxaban) in Elderly NVAF Patients
moreDaiichi Sankyo Announces the Presentation of New Data on LIXIANA® (edoxaban) to be Presented at ESC Congress 2019
moreTechnische Universität München
Atrial fibrillation: New marker for atrial damage discovered
moreData from the Non-interventional EMIT-AF/VTE Study Shows Low Thromboembolic and Bleeding Event Rates in Unselected Elderly AF/VTE Patients on Oral, Once-daily LIXIANA® Undergoing Diagnostic or Therapeutic Procedures
moreDaiichi Sankyo Presents Positive Results of the First Randomised, Controlled Trial of Uninterrupted Oral, Once-daily LIXIANA® (edoxaban) in Atrial Fibrillation Patients Undergoing Catheter Ablation
moreBAVENCIO® (avelumab) Plus INLYTA® (axitinib) Significantly Improved Progression-Free Survival in Previously Untreated Patients With Advanced Renal Cell Carcinoma in Phase III Study
moreReal-world Evidence From GARFIELD-AF Shows Superior Reduction in Mortality With Non-vitamin K Antagonists Oral Anticoagulants (NOACs) vs. Vitamin K Antagonists (VKAs) in Newly Diagnosed Atrial Fibrillation
moreThe Thrombosis Research Institute
Thrombosis Research Institute (TRI) to Announce New Real-World Insights in Atrial Fibrillation at ESC Congress 2018
more
1